AbCellera Biologics Inc. 4

Michael R. Hayden purchased 46,387 AbCellera Biologics Inc. Common Shares on August 12, 2026 at a weighted-average price of about $10.37 per share.

On August 12, 2026, insider Michael R. Hayden reported purchasing 46,387 Common Shares of AbCellera Biologics Inc. in the open market at a weighted-average price of approximately $10.37 per share, for an estimated total of about $481,000. The purchases occurred across multiple trades within a price range of $10.25 to $10.45 and increased his indirectly held position to 1,319,784 Common Shares. In addition, a separate indirect holding of 118,245 Common Shares is reported as owned by his spouse through Genworks 2 Consulting, Inc., for which Hayden disclaims beneficial ownership except for any indirect pecuniary interest.

Filing Facts

CIK

1703057

Ticker

ABCL

Form

4

Source Type

fda

Accession

0001628280-26-057007

Alert Tier

7